Decentralized Clinical Trials

Category

Independent Data Monitoring Committee Recommends Continuing COLCORONA Study Indicating Potential of Colchicine

Back in June, TrialSite introduced the COLCORONA study led by the Montreal Heart Institute—a Phase 3 randomized, double-blind, placebo-controlled multicenter trial evaluating the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection;...

Medable Expands Leadership in Decentralized Trials to Drive Growth: The TrialSite Interview

TrialSite recently interviewed a group of new leaders at the white-hot, decentralized clinical trial venture called Medable. The Silicon Valley-based decentralized trials platform announced strong momentum in the first half of 2020, as clinical trials sponsors pivot...

COVID-19 & the Disruption of Clinical Trials Worldwide: Readjustment in the Works

With long-lasting effects on medical science, reports Aaron van Dorn, the COVID-19 pandemic has created massive disruptions to clinical trial research across the world. As in other aspects of life, the virus has severely affected the ability to conduct trials in safe...

Emerging Decentralized Clinical Trials Mobile Platform Upstart Secures $25m and Fuel During Pivot from COVID-19

Medable, a Silicon Valley-based mobile app vendor seeking to decentralize clinical trials and reduce clinical trial timelines by 50%, has raised $25 million in funding to take their startup to the next level. The company seeks to help the drug development sector...

The Site-less Trial Commences with the Heartline Study Powered by Apple, Evidation Health & Janssen (J&J)

Johnson & Johnson’s Janssen Pharmaceutical unit inked a partnership with Apple to leverage the iPhone and FDA-complaint apps for a new study—the Heartline Study—designed to assess if apps on the iPhone and features on the Apple Watch can improve health outcomes...

Google Hires Top Digital Research Cardiologist Specialist in Moves to Ultimately Expand Fitbit Medical Research Competitive Position

A prominent figure in digital healthcare (including medical devices and AI) was approached by Google Health, reporting directly to Dr. Karen DeSalvo, Chief Health Officer. Dr. Jacqueline Shreibati leaves AliveCor where she served as Chief Medical Officer to take on an...

Stalin Adverse Event Monitoring Clinical Trial Powered by Silicon Valley-based Mobile App Platform

The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare selected Medable, Inc., a Palo Alto, CA, cloud-based clinical trial platform, to evaluate statin-related adverse events utilizing mobile accessible electronic patient-reported...

Pin It on Pinterest